Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection David R. DarleyLilibeth CarlosAllan R. Glanville Clinical Trial 12 March 2019 Pages: 879 - 888
A comparative study of two infusion doses of etomidate for induction vs standard induction dose of etomidate Prakash M. V. S. SatyaRajiv GnanasekarPrashant S. Adole Pharmacodynamics 29 April 2019 Pages: 889 - 894
Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium Philippe Van WilderMagali PirsonAlain Dupont Pharmacoeconomics 15 March 2019 Pages: 895 - 900
Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients Maki SasanoMasako OhnoMakiko Maeda Pharmacogenetics 09 March 2019 Pages: 901 - 911
Evaluation of the effects of ontogenetic or maturation functions and chronic heart failure on the model analysis for the dose-response relationship of warfarin in Japanese children Rika TamuraNao WatanabeMasato Taguchi Pharmacokinetics and Disposition 08 March 2019 Pages: 913 - 920
The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults Didi BuryRob ter HeineMaarten J. Deenen Pharmacokinetics and Disposition Open access 15 March 2019 Pages: 921 - 928
Relationship between hemoglobin levels and vancomycin clearance in patients with sepsis Masayuki ChumaMakoto MakishimaKosaku Kinoshita Pharmacokinetics and Disposition 14 March 2019 Pages: 929 - 937
Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population Anaïs GlatardMonia GuidiChin B. Eap Pharmacokinetics and Disposition 13 March 2019 Pages: 939 - 949
Reduction of exposure to tacrolimus trough level variability is associated with better graft survival after kidney transplantation Ruth RahamimovHagit Tifti-OrbachBenaya Rozen-Zvi Pharmacoepidemiology and Prescription 14 February 2019 Pages: 951 - 958
Use of statins in the elderly according to age and indication—a cross-sectional population-based register study Helena SundvallJohan FastbomSigurd Vitols Pharmacoepidemiology and Prescription Open access 03 March 2019 Pages: 959 - 967
Balancing medication use in nursing home residents with life-limiting disease Kristel PaqueMonique ElseviersTinne Dilles Pharmacoepidemiology and Prescription 04 March 2019 Pages: 969 - 977
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study Karin HedenmalmXavier KurzDaniel Morales Pharmacoepidemiology and Prescription Open access 05 March 2019 Pages: 979 - 984
Prevalence of medication and off-label medication use in acquired brain injury at a neurorehabilitation hospital Raquel MerinoAna PérezRosa Terré Pharmacoepidemiology and Prescription 05 March 2019 Pages: 985 - 994
Beliefs about medicines and information needs among pregnant women visiting a tertiary hospital in Belgium Michael CeulemansKristel Van CalsterenVeerle Foulon Pharmacoepidemiology and Prescription 04 March 2019 Pages: 995 - 1003
Antipsychotic utilization patterns among patients with schizophrenic disorder: a cross-national analysis in four countries Janet SultanaIsabel HurtadoGianluca Trifirò Pharmacoepidemiology and Prescription 01 March 2019 Pages: 1005 - 1015
A pharmacist-physician intervention model using a computerized alert system to reduce high-risk medication use in primary care Benoit CossetteRyeyan TaseenJean-François Éthier Pharmacoepidemiology and Prescription 21 March 2019 Pages: 1017 - 1023
Discontinuation of therapy among COPD patients who experience an improvement in exacerbation status Mette ReilevKasper Bruun KristensenAnton Pottegård Pharmacoepidemiology and Prescription 22 March 2019 Pages: 1025 - 1032